For research use only. Not for therapeutic Use.
Tunlametinib, an antineoplastic agent, is a tyrosine kinase inhibitor[1].
| Catalog Number | I037618 |
| CAS Number | 1801756-06-8 |
| Synonyms | 4-fluoro-5-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,3-benzothiazole-6-carboxamide |
| Molecular Formula | C16H12F2IN3O3S |
| Purity | ≥95% |
| InChI | InChI=1S/C16H12F2IN3O3S/c17-10-5-8(19)1-2-11(10)21-14-9(16(24)22-25-4-3-23)6-12-15(13(14)18)20-7-26-12/h1-2,5-7,21,23H,3-4H2,(H,22,24) |
| InChIKey | UFZJUVFSSINETF-UHFFFAOYSA-N |
| SMILES | C1=CC(=C(C=C1I)F)NC2=C(C3=C(C=C2C(=O)NOCCO)SC=N3)F |
| Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN) |
